Ojer Pharma (private company)

See something wrong or missing? Let us know
Offices:
Pamplona
Category:
Pharma
Business model:
B2B
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Ojer Pharma specializes in the development of innovative pharmaceutical products in the area of ​​dermatology.

Companies with similar profile to Ojer Pharma:

CompanyCriteria
Spain Ability Pharma
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Amadix
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Hetikus
44%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: < 1M USD
  • Minim one investor from outside Scandinavia: Yes
Iceland 3Z Pharmaceuticals
43%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
  • Minim one investor from outside Scandinavia: Yes
Spain buguroo
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain ProntoPiso
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Zinklar
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain AhÍmas Europa
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Parlem Telecom
34%
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Norway TAG Sensors
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Sanifit Therapeutics
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland Desentum
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark STipe Therapeutics
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Denmark NMD Pharma
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Sweden Asarina Pharma
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Spain Cleverea
33%
  • At least one vc investor: Inveready
  • Total raised in a similar range: < 1M USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Gnosco
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Total raised in a similar range: < 1M USD
Spain Bigfinite
33%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes